Varta
← Back to stories

From NDTV

Center-Right Owned by Adani Group (AMG Media)

Dr Lal PathLabs Q2 Review: Growth Guidance Raised, But Goldman Sachs Still Sees Valuation Risks

Dr Lal PathLabs Q2 Review: Growth Guidance Raised, But Goldman Sachs Still Sees Valuation Risks

RSS excerpt

Goldman Sachs maintained its Sell rating despite raising its target price to Rs 1,750 from Rs 1,700, citing expensive valuations. Kotak downgraded the stock to Add with a target price of Rs 2,300.

✦ Single Source 1 news outlet reporting

Fact-Check & Bias Analysis

Reported by a single newsroom so far. Other outlets have not independently corroborated this story yet.

Coverage Bias Distribution

Based on 1 reporting publisher
Left / Center-Left 0 (0%)
Center 0 (0%)
Center-Right / Right 1 (100%)

Read more news

See all latest stories →